Medical Weight Loss for Las Cruces, New Mexico Residents

Las Cruces, New Mexico residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Las Cruces through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Wondering if you qualify in Las Cruces? Eligibility for compounded GLP-1 care is confirmed by Dr. Sharma during your video visit, based on your health history, not your zip code in New Mexico. Doctor review just $119 (medication separate).

Why Las Cruces Residents Choose New Hope Weight Loss

New Hope was designed around the way Las Cruces residents actually live. You book your physician visit online, meet Dr. Anjmun Sharma by video, and if treatment makes sense your medication ships to your door. Everything runs through our Costa Mesa clinic by telehealth, so there is no local office to visit and no day off work required. The convenience is real, but the medical care behind it is the part we protect most.

Medical weight loss for Las Cruces is handled end-to-end online: intake, the $119 physician review with Dr. Sharma, dose titration, and follow-ups, all by secure video, with no drive and no pharmacy line.

If you are searching for a weight-loss physician in Las Cruces, the honest answer is that ours is in Costa Mesa, and thanks to telehealth that puts New Mexico patients exactly where local ones are. We care for patients throughout Downtown, the Mesilla area, and the greater southern New Mexico region. Follow-up check-ins are handled remotely, so adjusting your dose is simple whether you live near downtown Las Cruces or out toward Downtown, the Mesilla area, and the greater southern New Mexico region.

There are no local-office hours to fit your life around, so Las Cruces patients can meet Dr. Sharma on evenings or between work without crossing town. The 90-day semaglutide program is $499, which works out to a lower monthly cost than paying month to month for many Las Cruces patients. From the cities to the high desert of New Mexico, New Hope Weight Loss cares for patients entirely by telehealth from our Costa Mesa, California clinic, with no office visit needed.

GLP-1 Weight Loss Programs Available

Semaglutide 90-Day Metabolic Reset, from $166/mo

Most Las Cruces patients start here. Semaglutide shares its active ingredient with Wegovy and Ozempic, and in branded-drug trials people lost an average of 15 to 17 percent of body weight. Our program runs $499 for 90 days, with Dr. Sharma adjusting your dose each month by telehealth. Results vary, and compounded semaglutide is not FDA-approved or brand-identical.

Tirzepatide, from $233/mo

Tirzepatide works on two hunger pathways at once, GLP-1 and GIP. In trials of the branded drug, qualified patients reached up to 22.5 percent body-weight loss, which is a high-dose figure and not typical. It shares its active ingredient with Mounjaro and Zepbound.

$119 physician review. Medication is billed separately. We accept HSA, FSA, Klarna, and Affirm, with no surcharge for treating you in Las Cruces by telehealth.

How Telehealth Works for Las Cruces

Telehealth means your weight-loss care travels to you instead of the other way around. Patients across Las Cruces and the rest of start with a detailed online quiz covering medical history and goals. Dr. Anjmun Sharma personally reviews each intake and connects by secure video, usually inside 48 hours, to decide together whether a compounded GLP-1 is right. When she writes a prescription, the medication is filled by a state-licensed 503(a) pharmacy and mailed to your Las Cruces door in temperature-controlled cold-pack packaging. Ongoing follow-ups also happen by video, keeping your plan on track without a single in-person appointment.

Frequently Asked Questions, Las Cruces

Does New Hope Weight Loss have a presence in Las Cruces?

Our presence in Las Cruces is through telehealth rather than a storefront. The clinic itself is in Costa Mesa, California, our sole physical location. We serve Las Cruces, New Mexico patients online, and Dr. Anjmun Sharma confirms your eligibility for compounded semaglutide or tirzepatide during a private video consultation.

Could a Las Cruces patient complete care without leaving home?

Yes, staying home is the norm. Everything for Las Cruces patients runs over telehealth, including the initial consult, dose adjustments, and check-ins. After approval, your medication travels to Las Cruces in insulated cold-pack shipping that protects it from temperature swings during delivery.

How are Las Cruces patients charged?

There is a $119 fee for the physician review. Semaglutide starts at $166 monthly, with a 90-day option at $499, and tirzepatide at $233 monthly. The medication itself is a separate cost. We accept HSA, FSA, Klarna, and Affirm, and we add no distance surcharge for Las Cruces.

What areas of Las Cruces do you serve?

We serve patients from across Las Cruces by telehealth, including Downtown, the Mesilla area, and the greater southern New Mexico region.

How is medication shipped to Las Cruces patients?

After Dr. Sharma approves your plan, compounded medication ships in discreet, temperature-appropriate packaging directly to your Las Cruces address from the identified 503(a) compounding pharmacy. Most patients receive it within days, with no pharmacy line and no drive.

Las Cruces Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Las Cruces, New Mexico by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.